Mulder, Skander
University Medical Center Groningen · University of Groningen
2 papers on CoChatORCID 0000-0002-6910-3994
Most cited papers
- Verified
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 457
- Verified
Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes
Mulder, S., Heerspink, H. J. L., Darshi, M., Kim, J. J., Laverman, G. D., Sharma, K., & Pena, M. J. (2019) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free